The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 16, 2025 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Agrawal, trustee of the Aayush Agrawal Trust and promoter of Ajanta Pharma, has created a pledge on 2,60,000 shares (0.21% of total share capital) on June 9, 2025. The reason given is a change in lender, with the new pledge favouring Aditya Birla Money Ltd. After this event, the trust's total encumbered shares stand at 58,35,002 (4.67% of share capital), up from 55,75,002 earlier. The trust's overall promoter holding remains unchanged at 1,41,12,924 shares (11.30%). The disclosure was filed with BSE and NSE on June 16, 2025 under SEBI SAST Regulations.
This is a routine reshuffling of pledged shares between lenders, not a fresh increase in pledged exposure. Shareholders are unlikely to see a meaningful impact on stock price, though any sharp rise in pledged promoter shares warrants monitoring.